Gothenburg, Sweden March 1, 2018: W&H, one of the world’s leading manufacturers of dental precision instruments and devices, has acquired Osstell, the global leader in implant stability measurement and osseo integration progress monitoring.
Osstell’s innovative and patented technology helps its customers, dentists around the world, to make dental implant treatments even safer and more predictable, by measuring the stability of implants objectively and non-invasively using the ISQ technology (Implant Stability Quotient), and thereby helping clinicians improve patient confidence and comfort. Founded in 1999, Osstell developed the patented ISQ technology and the products are sold in more than 50 markets globally with operations in Sweden (Gothenburg), and the USA.
“Osstell and W&H have cooperated very successfully in the past, so it is a natural step that Osstell now becomes a part of W&H. As such, we get the opportunity for stronger and broader global representation, as well as greater delivery capacity – always with the aim to serve our customers and users with even better products and services as well as helping them to provide best practice services to their customers – the patients. Patients’ well-being is always the top priority,” says Mr. Jonas Ehinger, CEO Osstell.
“The aim is to further expand our expertise and thus strengthen our position as a specialist in oral implantology. The specialized company with its structure fits perfectly to the character of a family business, which is why we are confident that Osstell is a good fit and will become a valuable member of our W&H family,” says Mr. Peter Malata, W&H President and CEO.
Strategically, this acquisition is the next step in development of the surgical area for W&H, with the aim to broaden their competence and to strengthen their position as a leader within the field of implantology. The state-of-the-art technologies from both companies provide a unique capability benefitting both clinicians from all over the world and their patients.
The Osstell technology is currently available in a range of products, including in W&H’s latest generation Implantmed, an integrated solution that supports dental implant clinicians in their everyday practice. The ISQ measurements allow clinicians working with implants to make decisions based on reliable and objective stability values when determining the course of treatment for each patient. This procedure can be used to measure primary implant stability, observe osseo integration based on secondary stability readings and determine the best possible time for loading the implant, thereby helping to prevent failures and ensuring high quality.
About Osstell
Osstell is the global leader in implant stability measurement and osseo integration progress monitoring. Osstell was formed in 1999 to commercialize an invention using Resonance Frequency Analysis (RFA) to determine the clinical status of a dental implant. Osstell’s proprietary and patented technology helps its customers, dentists around the world, make dental implant treatments predictable, by measuring the stability of implants objectively with resonance frequency and using the ISQ scale (Implant Stability Quotient). More than 900 scientific publications confirm the benefits of the technology, its clinical value, and the use of the ISQ scale for dentists in their daily practice. Osstell is headquartered in Gothenburg, Sweden – the birthplace of dental implants.
About W&H Dentalwerk Bürmoos GmbH
The family-run business W&H Dentalwerk, based in Bürmoos near Salzburg, is Austria’s only manufacturer of dental precision instruments and devices and is one of the world’s leading dental companies. Innovative product and service solutions, a modern company structure, a strong focus on research and development, and social responsibility ensure W&H Dentalwerk’s success at both a local and global level. With some 1100 employees around the world (680 of whom work at the headquarters in Bürmoos), W&H exports its products to more than 110 countries. The family-run company operates two production sites in Bürmoos (Austria), one in Brusaporto (Italy) and 19 subsidiaries in Europe, Asia and North America.
Stay Relevant With Implant Practice US
Join our email list for CE courses and webinars, articles and mores
